CHARLOTTE, N.C. , May 5, 2021 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB) today announced its results for the first quarter ended March 31, 2021 . , First Quarter 2021 Highlights, (Unless otherwise stated, all percent changes are based on year-over-year comparisons) Net income of $95.7 million , or $0.84 per diluted share; Adjusted diluted EPS of $1.10 , an increase of 10% Net sales of $829.3 million , an increase of 12% Adjusted EBITDA of $230.1 million an increase of 17% Full year 2021 guidance unchanged Entered into a definitive agreement to sell the Fine Chemistry…, Outlook, Albemarle continues to expect its full year 2021 operating performance to improve modestly relative to full year 2020, assuming continued recovery from the global economic downturn. While the total company guidance has not changed, from a GBU perspective, the outlook for our Lithium business has improved and for our Catalysts business our expectations are lower, while the outlook for our Bromine…, FY 2021 Guidance, Net sales $3.2 - $3.3 billion Adjusted EBITDA $810 - $860 million Adjusted EBITDA Margin 25% - 26% Adjusted Diluted EPS $3.25 - $3.65 Net Cash from Operations $475 - $575 million Capital Expenditures $850 - $950 million, COVID-19 Response, Albemarle's cross-functional Global Response Team continues to meet regularly to address employee health and safety and operational challenges. Our priority is always the health and well-being of our employees, customers, and communities. Our focus has shifted from managing an immediate global crisis to building in the flexibility needed to adjust for regional differences and changing conditions…, First Quarter Results, In millions, except per share amounts, Q1 2021, Q1 2020, $ Change, % Change, Net sales $ 829.3 $ 738.8 $ 90.4 12.2 % Net income attributable to Albemarle Corporation $ 95.7 $ 107.2 $ (11.5) (10.8) % Adjusted EBITDA (a) $ 230.1 $ 196.4 $ 33.7 17.2 % Diluted earnings per share $ 0.84 $ 1.01 $ (0.17) (16.8) % Non-operating pension and OPEB items (a) (0.04) (0.02) Non-recurring and other unusual items (a) 0.29 0.01 Adjusted diluted earnings per share (b) $ 1.10 $ 1.00…, Business Segment Results, Lithium, In millions, Q1 2021, Q1 2020, $ Change, % Change, Net Sales $ 279.0 $ 236.8 $ 42.2 17.8 % Adjusted EBITDA $ 106.4 $ 78.6 $ 27.8 35.4 % Lithium net sales of $279.0 million increased $42.2 million primarily driven by higher volumes, as some customers accelerated orders under long-term agreements, offset by lower average pricing for carbonate and technical grade. Adjusted EBITDA of $106.4 million increased $27.8 million primarily due to increased…, Current Trends:, FY 2021 volumes are expected to be higher year-over-year due to North American plant restarts, productivity improvements, and tolling. Average realized pricing is expected to increase sequentially but remain flat compared to 2020. We expect higher costs related to project start-ups, partially offset by productivity improvements. , Bromine Specialties, In millions, Q1 2021, Q1 2020, $ Change, % Change, Net Sales $ 280.4 $ 231.6 $ 48.9 21.1 % Adjusted EBITDA $ 94.6 $ 83.3 $ 11.4 13.7 % Bromine net sales of $280.4 million increased $48.9 million driven by demand for products across the portfolio and a favorable customer mix. Adjusted EBITDA of $94.6 million increased $11.4 million due to increased net sales and was partially offset by a $6.4 million impact from the U.S. Gulf Coast winter storm.…, Current Trends:, We continue to expect FY 2021 results to be modestly higher than the previous year due to continued economic recovery and improvements in certain end markets, including electronics, and building and construction, along with on-going cost savings initiatives and pricing. The winter storm in the U.S. Gulf Coast during Q1 led to lost production at the Magnolia, Arkansas site, which is expected to…, Catalysts, In millions, Q1 2021, Q1 2020, $ Change, % Change, Net Sales $ 220.2 $ 207.2 $ 13.0 6.3 % Adjusted EBITDA $ 25.4 $ 47.5 $ (22.0) (46.4) % Catalysts net sales of $220.2 million increased $13.0 million owing to higher volumes compared to the previous year. Hydroprocessing Catalysts (HPC) volumes increased due to timing of shipments offset by lower Fluid Catalytic Cracking (FCC) volumes related to the impact of the winter storm on our customers'…, Current Trends:, We expect 2021 adjusted EBITDA to be lower year-over-year due to the impact of the winter storm, FCC order delays, product mix, and the previously disclosed change in order patterns from a large North American customer., All Other, In millions, Q1 2021, Q1 2020, $ Change, % Change, Net Sales $ 49.6 $ 63.2 $ (13.6) (21.5) % Adjusted EBITDA $ 21.5 $ 22.8 $ (1.3) (5.9) % Other operations represents our FCS business. FCS net sales of $49.6 million declined $13.6 million and adjusted EBITDA of $21.5 million declined $1.3 million . The FCS business tends to be contract driven and can vary quarter-to-quarter. On February 25, 2021 , we signed a definitive agreement to sell the FCS…, Balance Sheet and Liquidity, As of March 31, 2021 , Albemarle had estimated liquidity of approximately $2.2 billion , including $569.9 million of cash and equivalents, the full $1.0 billion available under our revolver, $500.0 million remaining under our delayed draw term loan and $131.2 million on other available credit lines. Total debt was $2.0 billion , representing net debt to adjusted EBITDA of approximately 1.7 times…, Cash Flow and Capital Deployment, Cash from operations for the three months ended March 31, 2021 , of $157.9 million increased $2.9 million versus the prior year as higher revenues in each of our reportable segments more than offset working capital outflows in 2021. Capital expenditures of $179.7 million decreased by approximately $35.0 million versus the prior year as the company nears completion of its Wave 2 Lithium expansion…, Earnings Call, Date: Thursday, May 6, 2021 Time: 9:00 AM Eastern time Dial-in ( U.S. ): 844-347-1034 Dial-in (International): 209-905-5910 Passcode: 9167449 The company's earnings presentation and supporting material are available on Albemarle's website at https://investors.albemarle.com ., About Albemarle, Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, N.C. , is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We think beyond business-as-usual to power the potential of companies in many of the world's largest and most critical industries, such as energy, electronics, and transportation. We actively pursue a sustainable approach…, Forward-Looking Statements, Some of the information presented in this press release, the conference call and discussions that follow, including, without limitation, information related to product development, production capacity, committed volumes, market trends, pricing, financial flexibility, expected growth, anticipated return on opportunities, earnings and demand for our products, input costs, productivity improvements…, Three Months Ended, March 31 ,, 2021, 2020, Net sales, $ 829,291 $ 738,845 Cost of goods sold 565,604 496,827, Gross profit, 263,687 242,018 Selling, general and administrative expenses 93,187 101,877 Research and development expenses 14,636 16,097, Operating profit, 155,864 124,044 Interest and financing expenses (43,882) (16,885) Other income, net 11,312 8,314 Income before income taxes and equity in net income of unconsolidated investments 123,294 115,473 Income tax expense 22,107 18,442 Income before equity in net income of unconsolidated investments 101,187 97,031 Equity in net income of unconsolidated investments (net of tax) 16,511 26,604 Net income…, March 31 ,, December 31 ,, 2021, 2020, ASSETS, Current assets: Cash and cash equivalents $ 569,859 $ 746,724 Trade accounts receivable 532,964 530,838 Other accounts receivable 60,558 61,958 Inventories 685,779 750,237 Other current assets 93,844 116,427 Assets held for sale 66,390 — Total current assets 2,009,394 2,206,184 Property, plant and equipment 7,433,593 7,427,641 Less accumulated depreciation and amortization 2,043,264 2,073,016…, LIABILITIES AND EQUITY, Current liabilities: Accounts payable $ 492,532 $ 483,221 Accrued expenses 378,973 440,763 Current portion of long-term debt 616 804,677 Dividends payable 45,327 40,937 Liabilities held for sale 4,068 — Income taxes payable 31,740 32,251 Total current liabilities 953,256 1,801,849 Long-term debt 2,030,032 2,767,381 Postretirement benefits 47,817 48,075 Pension benefits 316,652 340,818 Other…, Three Months Ended, March 31 ,, 2021, 2020, Cash and cash equivalents at beginning of year $ 746,724 $ 613,110 Cash flows from operating activities: Net income 117,698 123,635 Adjustments to reconcile net income to cash flows from operating activities: Depreciation and amortization 62,260 53,694 Stock-based compensation and other 2,560 2,501 Equity in net income of unconsolidated investments (net of tax) (16,511) (26,604) Dividends…, Three Months Ended, March 31 ,, 2021, 2020, Net sales:, Lithium $ 278,976 $ 236,818 Bromine Specialties 280,447 231,592 Catalysts 220,243 207,207 All Other 49,625 63,228 Total net sales $ 829,291 $ 738,845, Adjusted EBITDA:, Lithium $ 106,436 $ 78,637 Bromine Specialties 94,640 83,262 Catalysts 25,427 47,470 All Other 21,479 22,824 Corporate (17,928) (35,828) Total adjusted EBITDA $ 230,054 $ 196,365 See accompanying non-GAAP reconciliations below., Additional Information, It should be noted that adjusted net income attributable to Albemarle Corporation , adjusted diluted earnings per share, non-operating pension and OPEB items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA, EBITDA margin and adjusted EBITDA margin are financial measures that are not required by, or presented…, ALBEMARLE CORPORATION AND SUBSIDIARIES, Non-GAAP Reconciliations, (Unaudited), See below for a reconciliation of adjusted net income attributable to Albemarle Corporation , EBITDA and adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation ("earnings"), the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted earnings is defined as earnings before the non-recurring, other unusual…, Three Months Ended, March 31 ,, In thousands, except percentages and per share amounts, 2021, 2020, Net income attributable to Albemarle Corporation $ 95,677 $ 107,204 Add back: Non-operating pension and OPEB items (net of tax) (4,267) (2,311) Non-recurring and other unusual items (net of tax) 32,761 1,493 Adjusted net income attributable to Albemarle Corporation $ 124,171 $ 106,386 Adjusted diluted earnings per share $ 1.10 $ 1.00 Weighted-average common shares outstanding – diluted 113,330…, EBITDA, 223,926 196,225 Non-operating pension and OPEB items (5,465) (2,908) Non-recurring and other unusual items 11,593 3,048, Adjusted EBITDA, $ 230,054 $ 196,365 Net sales $ 829,291 $ 738,845 EBITDA margin 27.0 % 26.6 % Adjusted EBITDA margin 27.7 % 26.6 % See below for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to Net income attributable to Albemarle Corporation , the most directly comparable financial measure calculated and reported in accordance with GAAP (in thousands, except percentages…, Lithium, Bromine Specialties, Catalysts, Reportable Segments Total, All Other, Corporate, Consolidated Total, % of Net Sales, Three months ended March 31, 2021, Net income (loss) attributable to Albemarle Corporation $ 74,630 $ 82,113 $ 12,916 $ 169,659 $ 20,016 $ (93,998) $ 95,677 11.5 % Depreciation and amortization 31,806 12,527 12,511 56,844 1,463 3,953 62,260 7.5 % Non-recurring and other unusual items — — — — — 11,593 11,593 1.4 % Interest and financing expenses — — — — — 43,882 43,882 5.3 % Income tax expense — — — — — 22,107 22,107 2.7 % Non-…, Adjusted EBITDA, $ 106,436 $ 94,640 $ 25,427 $ 226,503 $ 21,479 $ (17,928) $ 230,054 27.7 %, Three months ended March 31, 2020, Net income (loss) attributable to Albemarle Corporation $ 53,240 $ 71,665 $ 34,892 $ 159,797 $ 20,846 $ (73,439) $ 107,204 14.5 % Depreciation and amortization 25,397 11,597 12,578 49,572 1,978 2,144 53,694 7.2 % Non-recurring and other unusual items — — — — — 3,048 3,048 0.4 % Interest and financing expenses — — — — — 16,885 16,885 2.3 % Income tax expense — — — — — 18,442 18,442 2.5 % Non-…, Adjusted EBITDA, $ 78,637 $ 83,262 $ 47,470 $ 209,369 $ 22,824 $ (35,828) $ 196,365 26.6 % Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to our operating segments and are included in the Corporate category. In addition, we believe that these components of pension cost are mainly…, Three Months Ended, March 31 ,, 2021, 2020, Interest cost $ 5,428 $ 7,155 Expected return on assets (10,893) (10,063) Total $ (5,465) $ (2,908) In addition to the non-operating pension and OPEB items disclosed above, we have identified certain other items and excluded them from our adjusted net income calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):, Three Months Ended, March 31 ,, 2021, 2020, Restructuring and other (1) $ — $ 0.01 Acquisition and integration related costs (2) 0.02 0.02 Loss on early extinguishment of debt (3) 0.20 — Other (4) 0.06 (0.01) Discrete tax items (5) 0.01 (0.01) Total non-recurring and other unusual items $ 0.29 $ 0.01 (1) In 2020, we recorded severance expenses as part of business reorganization plans, impacting each of our businesses and Corporate,…, Income before income taxes and equity in net income of unconsolidated investments, Income tax expense, Effective income tax rate, Three months ended March 31, 2021, As reported $ 123,294 $ 22,107 17.9 % Non-recurring, other unusual and non-operating pension and OPEB items 33,926 5,432 As adjusted $ 157,220 $ 27,539 17.5 %, Three months ended March 31, 2020, As reported $ 115,473 $ 18,442 16.0 % Non-recurring, other unusual and non-operating pension and OPEB items 461 958 As adjusted $ 115,934 $ 19,400 16.7 % View original content to download multimedia: http://www.prnewswire.com/news-releases/albemarle-reports-first-quarter-sales-growth-of-12-301284863.html SOURCE Albemarle Corporation Meredith Bandy, 980.999.5168
종류: Article